Zhi‐Ming Shao

Fudan University Shanghai Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Zhi‐Ming Shao is a leading figure in surgical oncology, with a primary focus on breast cancer treatment and the advancement of minimally invasive techniques. His major contributions lie in pioneering and evaluating endoscopic-assisted breast surgery (EABS), a field where he has systematically assessed clinical practices and outcomes. Notably, his 2025 nationwide cross-sectional survey, "Current practices and challenges of endoscopic-assisted breast surgery in China," has already garnered 4 citations, reflecting its timely impact on guiding surgical standards and identifying key barriers to adoption. Through this work, Shao has provided critical insights into the real-world implementation of EABS, addressing both technical challenges and patient selection criteria. His research bridges the gap between innovation and clinical practice, helping to shape safer, more effective breast cancer surgeries. As a respected authority in Chinese surgical oncology, Shao’s ongoing efforts continue to influence training protocols and policy recommendations, making him a pivotal voice in the global conversation on breast-conserving and reconstructive surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Fudan University Shanghai Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago